Navigation Links
Scientists seek out cancer cells hiding from treatment
Date:1/15/2013

Scientists hope to improve leukaemia treatment by investigating how cancer cells use 'hiding places' in the body to avoid chemotherapy drugs.

Each year 300 British children are diagnosed with acute lymphoblastic leukaemia, a cancer of the blood. The majority respond well to current therapies, but the disease returns in a quarter of patients. The long term outlook for adults is much worse, with initial treatments being effective in fewer than half of all patients.

Now, researchers from Imperial College London will begin a three year project to explore how some cancer cells evade treatment, thanks to new funding from blood cancer charity Leukaemia & Lymphoma Research.

Lead researcher, Dr Cristina Lo Celso, Lecturer in Immunology in Imperial's Department of Life Sciences, said: "We believe that some evasive cancer cells hide in protective compartments inside the body while patients receive treatment. If we understand where the cancer cells hide, we will be able to develop better ways to treat patients by eliminating all cancer cells and avoiding disease relapse."

Blood cells are produced in the bone marrow, where they grow and take on a variety of forms within compartments called niches inside bones. Dr Lo Celso's team believe that in the bones of Leukaemia patients, some of these compartments have been 'hijacked' by leukaemia cells, where they serve as effective hiding places during treatment. "Once we can see how this happens drugs can be developed that target the hiding places. This will have a dramatic impact on the design of new drugs for blood cancers like acute lymphoblastic leukaemia," she said.

Dr Lo Celso and colleague Dr Edwin Hawkins will use high powered microscopes in Imperial's Facility for Imaging by Light Microscopy (FILM) to observe cancer cells using fluorescent light. They will use this technique to track the movement of the evasive leukaemia cells in laboratory mice and hope to learn where these cells go during cancer treatment.

Professor Chris Bunce, Research Director at Leukaemia & Lymphoma Research, said: "Leukaemia occurs when the machinery that controls how blood cells grow and die breaks down. We now know that both normal blood cells and leukaemia cells are produced by a small number of stem cells that live inside compartments in our bone marrow. Understanding how these leukaemia cells hide from powerful anti-cancer drugs is vital to creating treatments for patients that will work faster and prevent the disease from returning."


'/>"/>

Contact: Simon Levey
s.levey@imperial.ac.uk
44-020-759-46702
Imperial College London
Source:Eurekalert

Related biology news :

1. Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs
2. Queens scientists seek vaccine for Pseudomonas infection
3. Scientists produce eye structures from human blood-derived stem cells
4. American Society of Plant Biologists honors early career women scientists
5. Brandeis scientists win prestigious prize for circadian rhythms research
6. Scientists discover new method of proton transfer
7. Salk scientists open new window into how cancers override cellular growth controls
8. WileyChina.com - Now Featuring Bespoke Pages for China’s Life Scientists
9. Scientists win $2 million to study new pathway in development and maintenance of lymphoma
10. UGA scientists reveal genetic mutation depicted in van Goghs sunflower paintings
11. Genetic mutation depicted in van Goghs sunflower paintings revealed by scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2016)... DUBAI , UAE, May 9, 2016 ... choice when it comes to expanding freedom for high ... Even in today,s globally connected world, there ... online conferencing system could ever duplicate sealing your deal ... are obtaining second passports by taking advantage of citizenship ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/19/2016)... UAE, April 20, 2016 The ... as a compact web-based "all-in-one" system solution for all ... fingerprint reader or the door interface with integration authorization ... access control systems. The minimal dimensions of the access ... into the building installations offer considerable freedom of design ...
Breaking Biology News(10 mins):
(Date:5/25/2016)... ... May 25, 2016 , ... Lajollacooks4u has become a rising ... been rated one of its top attractions. Fortune 500 companies, such as Illumina, ... a unique and intimate team-building experience. , Each event kicks off with an olive ...
(Date:5/25/2016)... ... May 25, 2016 , ... The American Medical ... Office of the National Coordinator for Health IT (ONC) outlining a measurement approach ... data were available when and where it was needed. The organization of health ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... and Drug Administration (FDA) has granted the company’s orphan drug designation request covering ... orphan drug designation granted by the FDA. , Spinocerebellar ataxia is a ...
(Date:5/24/2016)... ... May 24, 2016 , ... Media Cybernetics, global image ... Cybernetics corporate branding reflects a results-driven revitalization for a company with a renewed ... components include a crisp, refreshed logo and a new web presence. , “I ...
Breaking Biology Technology: